{"article_link": "https://www.frontiersin.org/articles/10.3389/fimmu.2022.938240/full", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010", "description": "Bulk RNA-seq data for unstimulated and stimulated naïve B cells.", "technology": "RNA sequencing", "experimental_group": "TACI mutation carriers and wild-type individuals"}, {"id": "data_2", "omics": "Genomics", "link": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA859010", "format": "FASTQ", "source": "Sequence Read Archive (SRA)", "public_id": "PRJNA859010", "description": "ATAC-seq data for unstimulated and stimulated naïve B cells.", "technology": "Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq)", "experimental_group": "TACI mutation carriers and wild-type individuals"}, {"id": "data_3", "omics": "Proteomics", "link": "http://www.proteomexchange.org/cgi/GetDataset?ID=PXD035459", "format": "Mass Spectrometry Raw Files", "source": "ProteomeXchange", "public_id": "PXD035459", "description": "Proteomics data for stimulated naïve B cells.", "technology": "LC-MS/MS", "experimental_group": "TACI mutation carriers and wild-type individuals"}], "analyses": [{"id": "analysis_1", "analysis_type": "ATAC-seq", "analysis_data": ["data_2"], "training_set": [], "test_set": [], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Chromatin accessibility mapping of naïve B cells."}, {"id": "analysis_2", "analysis_type": "Bulk RNA-seq", "analysis_data": ["data_1"], "training_set": [], "test_set": [], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Transcriptome profiling of naïve B cells."}, {"id": "analysis_3", "analysis_type": "Proteomics", "analysis_data": ["data_3"], "training_set": [], "test_set": [], "label": {"condition": ["stimulated"]}, "description": "Proteome profiling of stimulated naïve B cells."}, {"id": "analysis_4", "analysis_type": "Differential analysis", "analysis_data": ["analysis_1"], "training_set": [], "test_set": [], "label": {"group": ["TACI mutation carriers", "wild-type"]}, "description": "Differential analysis of chromatin accessibility using HOMER with thresholds of 10-fold greater tag density than background."}, {"id": "analysis_5", "analysis_type": "Differential analysis", "analysis_data": ["analysis_2"], "training_set": [], "test_set": [], "label": {"group": ["TACI mutation carriers", "wild-type"]}, "description": "Differential gene expression analysis using DESeq2 with adjusted p-value < 0.05 and log2 fold change > 0.5."}, {"id": "analysis_6", "analysis_type": "Differential analysis", "analysis_data": ["analysis_3"], "training_set": [], "test_set": [], "label": {"group": ["TACI mutation carriers", "wild-type"]}, "description": "Differential protein expression analysis using t-test with alpha = 0.05 and absolute log2 fold change of 0.5."}, {"id": "analysis_7", "analysis_type": "Gene set enrichment analysis", "analysis_data": ["analysis_2"], "training_set": [], "test_set": [], "label": {"condition": ["unstimulated", "stimulated"]}, "description": "Gene set enrichment analysis using fgsea with Hallmark pathways."}, {"id": "analysis_8", "analysis_type": "Gene set enrichment analysis", "analysis_data": ["analysis_3"], "training_set": [], "test_set": [], "label": {"condition": ["stimulated"]}, "description": "Gene set enrichment analysis using Hallmark pathways."}], "results": [{"analysis_id": "analysis_4", "metric": "number of differentially accessible regions (DARs)", "value": "1,356 (743 in TACI mutation carriers; 613 in wild-type)", "features": []}, {"analysis_id": "analysis_5", "metric": "number of differentially expressed genes (DEGs)", "value": "13 (5 upregulated and 8 downregulated genes with log2FC > 0.5 and adjusted p-value < 0.05)", "features": ["HLA-B", "NR4A2", "THEMIS2", "QPCT", "GADD45B", "CCNB3", "AXIN2", "ZNF235", "DNAJC12", "UBXN10", "MANSC1", "TRIP13", "JPT2"]}, {"analysis_id": "analysis_6", "metric": "number of differentially expressed proteins", "value": "3,805 (1,768 upregulated and 2,037 downregulated with log2FC > 0.5 and adjusted p-value < 0.05)", "features": []}, {"analysis_id": "analysis_7", "metric": "list of enriched pathways", "value": "", "features": ["TNF-a signaling via NF-kB", "hypoxia", "p53 signaling", "UV response", "interferon-a response", "fatty acid metabolism", "protein secretion", "oxidative phosphorylation", "complement", "inflammatory response", "allograft rejection", "MYC-V2 target genes"]}, {"analysis_id": "analysis_8", "metric": "list of enriched pathways", "value": "", "features": ["coagulation", "interferon-a (IFN-a)", "interferon-g (IFN-g)", "oxidative phosphorylation", "MYC-V2 target genes", "E2F targets", "DNA repair pathways"]}]}